Amag’s plan to bypass female libido drug pitfalls? Social media.

//Amag’s plan to bypass female libido drug pitfalls? Social media.

Amag’s plan to bypass female libido drug pitfalls? Social media.

Amag Pharmaceuticals Inc. has received regulatory approval to begin selling Vyleesi, a drug designed to address hypoactive sexual disorder, a condition in which causes low sexual desire and distress in an estimated one in 10 women.

Article by [author-name] (c) Health Care News - Health Care News Headlines | Bizjournals.com - Read full story here.

By | 2019-06-21T21:37:37+00:00 June 21st, 2019|Healthcare|

About the Author: